Literature DB >> 8461564

Fluoride salts for vertebral osteoporosis: the benefit-to-risk ratio depends on the cumulative dose reaching bone.

P J Meunier1, G Boivin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461564     DOI： 10.1007/bf01621910

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  12 in total

1.  Fluoride and vertebral fractures.

Authors:  N Mamelle; P J Meunier; P Netter
Journal:  Lancet       Date:  1990-07-28       Impact factor: 79.321

2.  Fluoride treatment for osteoporosis.

Authors:  C Nagant de Deuxchaisnes; J P Devogelaer; F Stein
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

Review 3.  Consensus development conference: prophylaxis and treatment of osteoporosis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

4.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

5.  Fluoride content in human iliac bone: results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride.

Authors:  G Boivin; M C Chapuy; C A Baud; P J Meunier
Journal:  J Bone Miner Res       Date:  1988-10       Impact factor: 6.741

6.  Treatment of osteoporosis with fluoride, calcium, and vitamin D.

Authors:  D Briancon; P J Meunier
Journal:  Orthop Clin North Am       Date:  1981-07       Impact factor: 2.472

7.  Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.

Authors:  P D Delmas; J Dupuis; F Duboeuf; M C Chapuy; P J Meunier
Journal:  J Bone Miner Res       Date:  1990-03       Impact factor: 6.741

8.  Skeletal fluorosis: histomorphometric analysis of bone changes and bone fluoride content in 29 patients.

Authors:  G Boivin; P Chavassieux; M C Chapuy; C A Baud; P J Meunier
Journal:  Bone       Date:  1989       Impact factor: 4.398

9.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

10.  Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

Authors:  N Mamelle; P J Meunier; R Dusan; M Guillaume; J L Martin; A Gaucher; A Prost; G Zeigler; P Netter
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
View more
  3 in total

1.  Fewer bone histomorphometric abnormalities with intermittent than with continuous slow-release sodium fluoride therapy.

Authors:  C M Schnitzler; J R Wing; F J Raal; M T van der Merwe; J M Mesquita; K A Gear; H J Robson; R Shires
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.

Authors:  G Guaydier-Souquières; P O Kotzki; J P Sabatier; B Basse-Cathalinat; G Loeb
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study.

Authors:  J L Sebert; P Richard; I Mennecier; J P Bisset; G Loeb
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.